CereVasc, Inc., a clinical-stage medical device company developing novel, minimally invasive treatments for neurological diseases, today announced the completion of enrollment in its ETCHES 1 Study of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback